swainsonine has been researched along with Adenocarcinoma, Papillary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujieda, S; Hoshino, T; Noda, I; Saito, H; Yagita, M | 1 |
1 other study(ies) available for swainsonine and Adenocarcinoma, Papillary
Article | Year |
---|---|
Swainsonine augments the cytotoxicity of human lymphokine-activated killer cells against autologous thyroid cancer cells.
Topics: Adenocarcinoma, Papillary; Adjuvants, Immunologic; Cytotoxicity, Immunologic; Fluorescent Antibody Technique; Granzymes; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Serine Endopeptidases; Swainsonine; Thyroid Neoplasms; Tumor Cells, Cultured | 1994 |